Australian Diabetes Educator
  • About
  • Browse
  • Contact Us
Toggle menu
Sort by:

Non-glycaemic benefits of medications for people living with type 2 diabetes

Volume 25, Number 2 - June 2022

There have been numerous advancements in the pharmacological management of type 2 diabetes (T2D) in recent years. Historically, the foundation of T2D...

BY Oscar Deane Klass |

Read More

Case study: Treatment Induced Neuropathy of Diabetes after rapid improvement in glycaemia following new diagnosis of autoimmune diabetes

Volume 25, Number 1 - March 2022

Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...

BY Margaret Loh |

Read More

Diabetic ketoacidosis in people with type 2 diabetes, recognising risk factors in addition to sodium-glucose cotransporter 2 inhibitors.

Volume 24, Number 1 - April 2021

Key Points:

...

BY Michelle Robins |

Read More

Consideration of Individual Health Goals During Pharmacotherapy Intensification for Type 2 Diabetes: A Case Study

Volume 23, Number 1 - April 2020

Optimal glycemic management for those living with type 2 diabetes (T2D) is essential to reduce the risk of macrovascular and microvascular...

BY Cristal Newman |

Read More

Guidelines in 2019 and what they mean for current practice

Volume 22, Number 2 - July 2019

International1,2 and Australian diabetes Guidelines3,4,5 have been focused on individualisation of diabetes care with risk...

BY Gary Deed |

Read More

Guidelines in 2019 and what they mean for current practice

Volume 22, Number 1 - March 2019
...

BY Gary Deed |

Read More
ADE
  • About
  • Browse
  • Contact Us
ADEA Research Foundation Australian Diabetes Education Assosiation
  • Privacy Statement
  • Disclaimer
  • Copyright and Permissions
  • Built by CRE8IVE
  • Managed by ADEA